Clinical Trial Update: Utility of Versican and Hyaluronan Measurement in Induced Sputum as Biomarkers of Asthma [Phase 4]

View source ↗

Summary

This Phase 4 clinical trial evaluated whether measuring versican and hyaluronan in induced sputum can serve as biomarkers for asthma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Allergic Asthma
• Asthma

Snippet

Sponsor: Associated Scientists to Help Minimize Allergies | Conditions: Allergic Asthma | Phase 4 | Status: COMPLETED